Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,413	676	1,350	1,900	1,391	610
Market Cap Growth	59.58%	-49.94%	-28.99%	36.58%	128.10%	-34.65%
Enterprise Value	1,538	446	1,251	1,609	1,177	416
Last Close Price	18.10	8.99	21.03	31.04	27.25	14.20
PE Ratio	-	-5.99	-4.81	-10.31	-7.65	-4.11
PS Ratio	6.87	4.65	12.33	14.42	7.02	3.48
PB Ratio	-35.14	3.36	31.49	6.29	6.59	2.76
P/FCF Ratio	-3.93	-2.41	-7.24	-95.53	-28.10	-10.44
P/OCF Ratio	-3.93	-2.41	-7.24	-128.48	-32.55	-10.48
EV/Sales Ratio	7.56	3.07	11.43	12.21	5.93	2.37
EV/EBITDA Ratio	-4.81	-1.32	-4.18	-8.62	-23.16	-5.24
EV/EBIT Ratio	-4.10	-1.18	-3.91	-8.07	-15.61	-4.17
EV/FCF Ratio	-4.22	-1.59	-6.71	-80.90	-23.76	-7.12
Debt / Equity Ratio	-13.21	2.02	9.51	0.87	1.16	0.93
Debt / FCF Ratio	-1.48	-1.44	-2.19	-13.17	-4.93	-3.51
Asset Turnover	0.30	0.20	0.15	0.19	0.33	0.27
Inventory Turnover	16.58	36.81	39.16	27.47	20.15	24.99
Quick Ratio	1.61	3.33	3.30	4.59	4.26	4.38
Current Ratio	1.71	3.47	3.42	4.70	4.43	4.50
Return on Equity (ROE)	-279.94%	-308.90%	-192.18%	-84.66%	-78.37%	-54.29%
Return on Assets (ROA)	-26.14%	-32.22%	-27.58%	-18.01%	-7.77%	-9.50%
Return on Capital (ROIC)	-33.07%	-44.60%	-39.41%	-24.45%	-10.69%	-12.97%
Earnings Yield	-24.88%	-16.49%	-20.63%	-9.48%	-12.18%	-24.00%
FCF Yield	-19.28%	-41.55%	-13.82%	-1.05%	-3.56%	-9.58%
Buyback Yield / Dilution	-8.47%	-16.48%	-6.56%	-25.86%	-12.28%	-4.72%
Total Shareholder Return	-8.47%	-16.48%	-6.56%	-25.86%	-12.28%	-4.72%

Source: S&P Capital IQ. Standard template. Financial Sources.